drugset / Trial / NCT06430112
Liposomal Bupivacaine vs Ropivacaine for TAPBs
RandomizedParallel-groupSingle-blindTreatment
Summary
Few studies have compared the efficacy of ultrasound (US)-guided TAP blocks with Liposomal bupivacaine(LB) versus ropivacaine in reducing postoperative opioid usage in patients undergoing laparoscopic lower abdominal tumor Resection. Therefore, we are conducting this prospective, randomized controlled trial to compare the postoperative analgesic effects of LB and ropivacaine for TAP blocks among patients undergoing laparoscopic colorectal procedures.
Timeline
- Start
- 2023-11-01
- Primary completion
- 2024-05-20
- Completion
- 2024-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |
| Comparator | Ropivacaine | Other / unclassified | 0.25 % | Other |
| Comparator | Ropivacaine | Other / unclassified | 40 ml | Other |
Indications
No indication recorded.